Camptodactyly-Arthropathy-Coxa Vara-Pericarditis Syndrome Resembling Juvenile Idiopathic Arthritis: A Single-Center Experience from Southern Turkey
暂无分享,去创建一个
Celal Varan | S. Balcı | Sevcan Erdem | S. Ceylaner | A. Bişgin | Rabia Miray Kışla Ekinci | H. Doğan | Fatma Çoban | H. Dogan
[1] Mark W. Youngblood,et al. Genotype–phenotype investigation of 35 patients from 11 unrelated families with camptodactyly–arthropathy–coxa vara–pericarditis (CACP) syndrome , 2018, Molecular genetics & genomic medicine.
[2] S. Al‐Mayouf,et al. The Efficacy of Yttrium-90 Radiosynovectomy in Patients with Camptodactyly-Arthropathy-Coxa Vara-Pericarditis Syndrome , 2017, Molecular imaging and radionuclide therapy.
[3] A. Dalal,et al. Brothers with constrictive pericarditis – A novel mutation in a rare disease , 2016, Indian heart journal.
[4] M. Prakash,et al. Camptodactyly-arthropathy-coxa vara-pericarditis (CACP) syndrome: a mimicker of juvenile idiopathic arthritis , 2016, Scandinavian journal of rheumatology.
[5] G. Jay,et al. The interaction of lubricin/proteoglycan 4 (PRG4) with toll-like receptors 2 and 4: an anti-inflammatory role of PRG4 in synovial fluid , 2015, Arthritis Research & Therapy.
[6] Tannin A Schmidt,et al. Lubricin/Proteoglycan 4 Binding to CD44 Receptor: A Mechanism of the Suppression of Proinflammatory Cytokine–Induced Synoviocyte Proliferation by Lubricin , 2015, Arthritis & rheumatology.
[7] T. Kendirli,et al. Camptodactyly-arthropathy-coxa vara-pericarditis (CACP) syndrome. , 2014, The Turkish journal of pediatrics.
[8] R. Cate,et al. CACP syndrome: identification of five novel mutations and of the first case of UPD in the largest European cohort , 2013, European Journal of Human Genetics.
[9] S. Al‐Mayouf,et al. Camptodactyly-arthropathy-coxavara-pericarditis syndrome in Saudi Arabia: clinical and molecular genetic findings in 22 patients. , 2013, Seminars in arthritis and rheumatism.
[10] Tannin A Schmidt,et al. Transcription, translation, and function of lubricin, a boundary lubricant, at the ocular surface. , 2013, JAMA ophthalmology.
[11] L. Al-Gazali,et al. A novel mutation in PRG4 gene underlying camptodactyly-arthropathy-coxa vara-pericarditis syndrome with the possible expansion of the phenotype to include congenital cataract. , 2012, Birth defects research. Part A, Clinical and molecular teratology.
[12] S. Basit,et al. A novel deletion mutation in proteoglycan-4 underlies camptodactyly-arthropathy-coxa-vara-pericarditis syndrome in a consanguineous pakistani family. , 2011, Archives of medical research.
[13] Niclas G Karlsson,et al. The glycosylation of human synovial lubricin: implications for its role in inflammation. , 2010, The Biochemical journal.
[14] A. Alazami,et al. Novel PRG4 mutations underlie CACP in Saudi families , 2006, Human mutation.
[15] Y. Nakamura,et al. Isolation, characterization and mapping of the mouse and human PRG4 (proteoglycan 4) genes , 2000, Cytogenetic and Genome Research.
[16] S. Schwartz,et al. CACP, encoding a secreted proteoglycan, is mutated in camptodactyly-arthropathy-coxa vara-pericarditis syndrome , 1999, Nature Genetics.
[17] H. Yazici,et al. A familial syndrome of pericarditis, arthritis, camptodactyly, and coxa vara. , 1986, Arthritis and rheumatism.